Histone H2B type 1-O (Histone H2B.2) (Histone H2B.n) (H2B/n) | HIST1H2BO H2BFH H2BFN | P23527 | 4 |
Histone H2B type 3-B (H2B type 12) | HIST3H2BB | Q8N257 | 4 |
Histone RNA hairpin-binding protein (Histone stem-loop-binding protein) | SLBP HBP | Q14493 | 4 |
Histone-binding protein RBBP7 (Histone acetyltransferase type B subunit 2) (Nucleosome-remodeling factor subunit RBAP46) (Retinoblastoma-binding protein 7) (RBBP-7) (Retinoblastoma-binding protein p46) | RBBP7 RBAP46 | Q16576 | 4 |
Histone-lysine N-methyltransferase EZH2 (EC 2.1.1.43) (ENX-1) (Enhancer of zeste homolog 2) (Lysine N-methyltransferase 6) | EZH2 KMT6 | Q15910 | 4 |
Histone-lysine N-methyltransferase SETDB1 (EC 2.1.1.43) (ERG-associated protein with SET domain) (ESET) (Histone H3-K9 methyltransferase 4) (H3-K9-HMTase 4) (Lysine N-methyltransferase 1E) (SET domain bifurcated 1) | SETDB1 KIAA0067 KMT1E | Q15047 | 4 |
Histone-lysine N-methyltransferase SUV420H1 (EC 2.1.1.43) (Lysine N-methyltransferase 5B) (Suppressor of variegation 4-20 homolog 1) (Su(var)4-20 homolog 1) (Suv4-20h1) | SUV420H1 KMT5B CGI-85 | Q4FZB7 | 4 |
HLA class I histocompatibility antigen, A-2 alpha chain (MHC class I antigen A*2) | HLA-A HLAA | P01892 | 4 |
HLA class II histocompatibility antigen gamma chain (HLA-DR antigens-associated invariant chain) (Ia antigen-associated invariant chain) (Ii) (p33) (CD antigen CD74) | CD74 DHLAG | P04233 | 4 |
HLA class II histocompatibility antigen, DO beta chain (MHC class II antigen DOB) | HLA-DOB | P13765 | 4 |
HLA class II histocompatibility antigen, DP alpha 1 chain (DP(W3)) (DP(W4)) (HLA-SB alpha chain) (MHC class II DP3-alpha) (MHC class II DPA1) | HLA-DPA1 HLA-DP1A HLASB | P20036 | 4 |
HNRNPL protein (Fragment) | HNRNPL | Q6NTA2 | 4 |
Homeobox protein aristaless-like 3 (Proline-rich transcription factor ALX3) | ALX3 | O95076 | 4 |
Homeobox protein engrailed-2 (Homeobox protein en-2) (Hu-En-2) | EN2 | P19622 | 4 |
Homeobox protein Hox-A5 (Homeobox protein Hox-1C) | HOXA5 HOX1C | P20719 | 4 |
Homeobox protein Hox-A9 (Homeobox protein Hox-1G) | HOXA9 HOX1G | P31269 | 4 |
Homeobox protein Hox-B5 (Homeobox protein HHO.C10) (Homeobox protein Hox-2A) (Homeobox protein Hu-1) | HOXB5 HOX2A | P09067 | 4 |
Homeobox protein Hox-B6 (Homeobox protein Hox-2.2) (Homeobox protein Hox-2B) (Homeobox protein Hu-2) | HOXB6 HOX2B | P17509 | 4 |
Homeobox protein Hox-D4 (Homeobox protein HHO.C13) (Homeobox protein Hox-4B) (Homeobox protein Hox-5.1) | HOXD4 HOX4B | P09016 | 4 |
Homeobox protein MSX-1 (Homeobox protein Hox-7) (Msh homeobox 1-like protein) | MSX1 HOX7 | P28360 | 4 |
Homeobox protein Nkx-2.3 (Homeobox protein NK-2 homolog C) | NKX2-3 NKX23 NKX2C | Q8TAU0 | 4 |
Homeodomain-interacting protein kinase 2 (hHIPk2) (EC 2.7.11.1) | HIPK2 | Q9H2X6 | 4 |
Hormone-sensitive lipase (HSL) (EC 3.1.1.79) | LIPE | Q05469 | 4 |
HSPC193 | 0 | Q9P0T0 | 4 |
Huntingtin-interacting protein K (Huntingtin yeast partner K) | HYPK C15orf63 HSPC136 | Q9NX55 | 4 |
Hyaluronan and proteoglycan link protein 1 (Cartilage-linking protein 1) (Cartilage-link protein) (Proteoglycan link protein) | HAPLN1 CRTL1 | P10915 | 4 |
Hyaluronidase-1 (Hyal-1) (EC 3.2.1.35) (Hyaluronoglucosaminidase-1) (Lung carcinoma protein 1) (LuCa-1) | HYAL1 LUCA1 | Q12794 | 4 |
Hypermethylated in cancer 1 protein (Hic-1) (Zinc finger and BTB domain-containing protein 29) | HIC1 ZBTB29 | Q14526 | 4 |
ICOS ligand (Inducible T-cell co-stimulator ligand, isoform CRA_a) (cDNA FLJ33173 fis, clone ADRGL2002191, highly similar to ICOS ligand) | ICOSLG hCG_401312 | A8MUZ1 | 4 |
Immunoglobulin superfamily member 21 (IgSF21) | IGSF21 | Q96ID5 | 4 |
Inactive serine protease PAMR1 (Peptidase domain-containing protein associated with muscle regeneration 1) (Regeneration-associated muscle protease homolog) | PAMR1 RAMP FP938 UNQ699/PRO1344 | Q6UXH9 | 4 |
Inhibin beta C chain (Activin beta-C chain) | INHBC | P55103 | 4 |
Inosine triphosphate pyrophosphatase (ITPase) (Inosine triphosphatase) (EC 3.6.1.19) (Non-canonical purine NTP pyrophosphatase) (Non-standard purine NTP pyrophosphatase) (Nucleoside-triphosphate diphosphatase) (Nucleoside-triphosphate pyrophosphatase) (NTPase) (Putative oncogene protein hlc14-06-p) | ITPA C20orf37 My049 OK/SW-cl.9 | Q9BY32 | 4 |
Inositol monophosphatase 2 (IMP 2) (IMPase 2) (EC 3.1.3.25) (Inositol-1(or 4)-monophosphatase 2) (Myo-inositol monophosphatase A2) | IMPA2 IMP.18P | O14732 | 4 |
Inositol polyphosphate 1-phosphatase (IPP) (IPPase) (EC 3.1.3.57) | INPP1 | P49441 | 4 |
Inositol polyphosphate 5-phosphatase OCRL-1 (EC 3.1.3.36) (Lowe oculocerebrorenal syndrome protein) | OCRL INPP5F OCRL1 | Q01968 | 4 |
Insulin-like 3 (Leydig insulin-like peptide) (Ley-I-L) (Relaxin-like factor) [Cleaved into: Insulin-like 3 B chain; Insulin-like 3 A chain] | INSL3 RLF RLNL | P51460 | 4 |
Insulin-like growth factor binding protein, acid labile subunit | IGFALS | Q8TAY0 | 4 |
Insulin-like growth factor-binding protein 2 (IBP-2) (IGF-binding protein 2) (IGFBP-2) | IGFBP2 BP2 IBP2 | P18065 | 4 |
Insulin-like growth factor-binding protein 3 (IBP-3) (IGF-binding protein 3) (IGFBP-3) | IGFBP3 IBP3 | P17936 | 4 |
Insulin-like growth factor-binding protein 7 (IBP-7) (IGF-binding protein 7) (IGFBP-7) (IGFBP-rP1) (MAC25 protein) (PGI2-stimulating factor) (Prostacyclin-stimulating factor) (Tumor-derived adhesion factor) (TAF) | IGFBP7 MAC25 PSF | Q16270 | 4 |
Integrator complex subunit 1 (Int1) | INTS1 KIAA1440 UNQ1821/PRO3434 | Q8N201 | 4 |
Integrator complex subunit 7 (Int7) | INTS7 C1orf73 | Q9NVH2 | 4 |
Integrator complex subunit 9 (Int9) (Protein related to CPSF subunits of 74 kDa) (RC-74) | INTS9 RC74 | Q9NV88 | 4 |
Integrin beta-2 (Cell surface adhesion glycoproteins LFA-1/CR3/p150,95 subunit beta) (Complement receptor C3 subunit beta) (CD antigen CD18) | ITGB2 CD18 MFI7 | P05107 | 4 |
Inter-alpha-trypsin inhibitor heavy chain H6 (Inter-alpha-trypsin inhibitor heavy chain H5-like protein) (Inter-alpha inhibitor H5-like protein) | ITIH6 ITIH5L UNQ6369/PRO21074 | Q6UXX5 | 4 |
Interferon alpha-4 (IFN-alpha-4) (Interferon alpha-4B) (Interferon alpha-76) (Interferon alpha-M1) | IFNA4 | P05014 | 4 |
Interferon alpha/beta receptor 2 (IFN-R-2) (IFN-alpha binding protein) (IFN-alpha/beta receptor 2) (Interferon alpha binding protein) (Type I interferon receptor 2) | IFNAR2 IFNABR IFNARB | P48551 | 4 |
Interferon regulatory factor 5 (IRF-5) | IRF5 | Q13568 | 4 |
Interferon regulatory factor 7 (IRF-7) | IRF7 | Q92985 | 4 |
Interferon regulatory factor 9 (IRF-9) (IFN-alpha-responsive transcription factor subunit) (ISGF3 p48 subunit) (Interferon-stimulated gene factor 3 gamma) (ISGF-3 gamma) (Transcriptional regulator ISGF3 subunit gamma) | IRF9 ISGF3G | Q00978 | 4 |
Interferon-induced protein with tetratricopeptide repeats 5 (IFIT-5) (Interferon-induced 58 kDa protein) (Retinoic acid- and interferon-inducible 58 kDa protein) (P58) | IFIT5 ISG58 RI58 | Q13325 | 4 |
Interferon-inducible protein AIM2 (Absent in melanoma 2) | AIM2 | O14862 | 4 |
Interleukin 4 (Interleukin 4, isoform CRA_a) | IL4 hCG_24113 | D4HNR6 | 4 |
Interleukin-1 receptor accessory protein (IL-1 receptor accessory protein) (IL-1RAcP) (Interleukin-1 receptor 3) (IL-1R-3) (IL-1R3) | IL1RAP C3orf13 IL1R3 | Q9NPH3 | 4 |
Interleukin-11 receptor subunit alpha (IL-11 receptor subunit alpha) (IL-11R subunit alpha) (IL-11R-alpha) (IL-11RA) | IL11RA | Q14626 | 4 |
Interleukin-15 receptor subunit alpha (IL-15 receptor subunit alpha) (IL-15R-alpha) (IL-15RA) (CD antigen CD215) [Cleaved into: Soluble interleukin-15 receptor subunit alpha (sIL-15 receptor subunit alpha) (sIL-15R-alpha) (sIL-15RA)] | IL15RA | Q13261 | 4 |
Interleukin-17 receptor E (IL-17 receptor E) (IL-17RE) | IL17RE UNQ3056/PRO9877 | Q8NFR9 | 4 |
Interleukin-17D (IL-17D) (Interleukin-27) (IL-27) | IL17D IL27 UNQ3096/PRO21175 | Q8TAD2 | 4 |
Interleukin-18-binding protein (IL-18BP) (Tadekinig-alfa) | IL18BP | O95998 | 4 |
Interleukin-24 (IL-24) (Melanoma differentiation-associated gene 7 protein) (MDA-7) (Suppression of tumorigenicity 16 protein) | IL24 MDA7 ST16 | Q13007 | 4 |
Interleukin-36 receptor antagonist protein (FIL1 delta) (IL-1-related protein 3) (IL-1RP3) (Interleukin-1 HY1) (IL-1HY1) (Interleukin-1 delta) (IL-1 delta) (Interleukin-1 family member 5) (IL-1F5) (Interleukin-1 receptor antagonist homolog 1) (IL-1ra homolog 1) (Interleukin-1-like protein 1) (IL-1L1) | IL36RN FIL1D IL1F5 IL1HY1 IL1L1 IL1RP3 UNQ1896/PRO4342 | Q9UBH0 | 4 |
Intermediate filament family orphan 1 (Tumor antigen HOM-TES-103) | IFFO1 IFFO | Q0D2I5 | 4 |
Intraflagellar transport protein 27 homolog (Putative GTP-binding protein RAY-like) (Rab-like protein 4) | IFT27 RABL4 RAYL | Q9BW83 | 4 |
Intraflagellar transport protein 43 homolog | IFT43 C14orf179 | Q96FT9 | 4 |
Intraflagellar transport protein 80 homolog (WD repeat-containing protein 56) | IFT80 KIAA1374 WDR56 | Q9P2H3 | 4 |
Intron-binding protein aquarius (Intron-binding protein of 160 kDa) (IBP160) | AQR KIAA0560 | O60306 | 4 |
IQ calmodulin-binding motif-containing protein 1 (Nephrocystin-5) (p53 and DNA damage-regulated IQ motif protein) (PIQ) | IQCB1 KIAA0036 NPHP5 OK/SW-cl.85 | Q15051 | 4 |
IQ domain-containing protein C | IQCC | Q4KMZ1 | 4 |
IQ motif and SEC7 domain-containing protein 2 | IQSEC2 KIAA0522 | Q5JU85 | 4 |
Iron-sulfur protein NUBPL (IND1 homolog) (Nucleotide-binding protein-like) (huInd1) | NUBPL C14orf127 | Q8TB37 | 4 |
Iroquois-class homeodomain protein IRX-4 variant 1 (Iroquois-class homeodomain protein IRX-4 variant 3) | IRX4 | H1AFL0 | 4 |
JM11 protein, isoform CRA_a (cDNA FLJ76847, highly similar to Homo sapiens JM11 protein (JM11), mRNA) (cDNA, FLJ79486, weakly similar to FERM domain-containing protein 4B) | JM11 hCG_1749782 | A8K5Q5 | 4 |
Josephin-1 (EC 3.4.19.12) (Josephin domain-containing protein 1) | JOSD1 JSPH1 KIAA0063 | Q15040 | 4 |
Junctional adhesion molecule-like (Adhesion molecule interacting with CXADR antigen 1) (Dendritic cell-specific protein CREA7-1) | AMICA1 JAML UNQ722/PRO1387 | Q86YT9 | 4 |
Junctional sarcoplasmic reticulum protein 1 (Junctional-face membrane protein of 45 kDa homolog) (JP-45) | JSRP1 JP45 | Q96MG2 | 4 |
Kallikrein-14 (hK14) (EC 3.4.21.-) (Kallikrein-like protein 6) (KLK-L6) | KLK14 KLKL6 | Q9P0G3 | 4 |
Kallikrein-2 (EC 3.4.21.35) (Glandular kallikrein-1) (hGK-1) (Tissue kallikrein-2) | KLK2 | P20151 | 4 |
Kallikrein-8 (hK8) (EC 3.4.21.118) (Neuropsin) (NP) (Ovasin) (Serine protease 19) (Serine protease TADG-14) (Tumor-associated differentially expressed gene 14 protein) | KLK8 NRPN PRSS19 TADG14 UNQ283/PRO322 | O60259 | 4 |
KAT8 regulatory NSL complex subunit 2 (NSL complex protein NSL2) (Non-specific lethal 2 homolog) | KANSL2 C12orf41 NSL2 | Q9H9L4 | 4 |
Katanin p60 ATPase-containing subunit A1 (Katanin p60 subunit A1) (EC 3.6.4.3) (p60 katanin) | KATNA1 | O75449 | 4 |
Kelch domain-containing protein 2 (Hepatocellular carcinoma-associated antigen 33) (Host cell factor homolog LCP) (Host cell factor-like protein 1) (HCLP-1) | KLHDC2 HCA33 | Q9Y2U9 | 4 |
Kelch domain-containing protein 4 | KLHDC4 | Q8TBB5 | 4 |
Kelch domain-containing protein 7A | KLHDC7A | Q5VTJ3 | 4 |
Kelch repeat and BTB domain-containing protein 11 (Chronic myelogenous leukemia-associated protein) (Kelch domain-containing protein 7B) | KBTBD11 CMLAP KIAA0711 KLHDC7C | O94819 | 4 |
Kelch-like protein 12 (CUL3-interacting protein 1) (DKIR homolog) (hDKIR) | KLHL12 C3IP1 | Q53G59 | 4 |
Kelch-like protein 3 | KLHL3 KIAA1129 | Q9UH77 | 4 |
Keratin, type I cytoskeletal 13 (Cytokeratin-13) (CK-13) (Keratin-13) (K13) | KRT13 | P13646 | 4 |
Keratin, type II cytoskeletal 1 (67 kDa cytokeratin) (Cytokeratin-1) (CK-1) (Hair alpha protein) (Keratin-1) (K1) (Type-II keratin Kb1) | KRT1 KRTA | P04264 | 4 |
Keratin, type II cytoskeletal 5 (58 kDa cytokeratin) (Cytokeratin-5) (CK-5) (Keratin-5) (K5) (Type-II keratin Kb5) | KRT5 | P13647 | 4 |
Keratin, type II cytoskeletal 6B (Cytokeratin-6B) (CK-6B) (Keratin-6B) (K6B) (Type-II keratin Kb10) | KRT6B K6B KRTL1 | P04259 | 4 |
Keratin, type II cytoskeletal 71 (Cytokeratin-71) (CK-71) (Keratin-71) (K71) (Type II inner root sheath-specific keratin-K6irs1) (Keratin 6 irs) (hK6irs) (hK6irs1) (Type-II keratin Kb34) | KRT71 K6IRS1 KB34 KRT6IRS1 | Q3SY84 | 4 |
Keratin, type II cytoskeletal 79 (Cytokeratin-79) (CK-79) (Keratin-6-like) (Keratin-6L) (Keratin-79) (K79) (Type-II keratin Kb38) | KRT79 K6L KB38 KRT6L | Q5XKE5 | 4 |
Keratin-associated protein 12-1 (High sulfur keratin-associated protein 12.1) (Keratin-associated protein 12.1) | KRTAP12-1 KAP12.1 KRTAP12.1 | P59990 | 4 |
Keratin-associated protein 19-1 (High tyrosine-glycine keratin-associated protein 19.1) | KRTAP19-1 KAP19.1 KRTAP19.1 | Q8IUB9 | 4 |
Keratin-associated protein 5-10 (Keratin-associated protein 5.10) (Ultrahigh sulfur keratin-associated protein 5.10) | KRTAP5-10 KAP5.10 KRTAP5.10 | Q6L8G5 | 4 |
Keratin-associated protein 5-2 (Keratin-associated protein 5-8) (Keratin-associated protein 5.2) (Keratin-associated protein 5.8) (Ultrahigh sulfur keratin-associated protein 5.2) | KRTAP5-2 KAP5-8 KAP5.2 KRTAP5-8 KRTAP5.2 KRTAP5.8 | Q701N4 | 4 |
Keratin-associated protein 5-5 (Keratin-associated protein 5-11) (Keratin-associated protein 5.11) (Keratin-associated protein 5.5) (Ultrahigh sulfur keratin-associated protein 5.5) | KRTAP5-5 KAP5-11 KAP5.5 KRTAP5-11 KRTAP5.11 KRTAP5.5 | Q701N2 | 4 |
Keratin-associated protein 9-2 (Keratin-associated protein 9.2) (Ultrahigh sulfur keratin-associated protein 9.2) | KRTAP9-2 KAP9.2 KRTAP9.2 | Q9BYQ4 | 4 |
Killer cell immunoglobulin-like receptor 3DL2 (CD158 antigen-like family member K) (MHC class I NK cell receptor) (Natural killer-associated transcript 4) (NKAT-4) (p70 natural killer cell receptor clone CL-5) (p70 NK receptor CL-5) (CD antigen CD158k) | KIR3DL2 CD158K NKAT4 | P43630 | 4 |